The frequency, clinical and laboratory features of RSV in small children with bronchiolitis;Bronşiyolit tanisiyla izlenen küçük çocuklarda RSV sikliǧi, klinik ve laboratuvar özellikleri

Turk Pediatri Arsivi

Volumn 45, Issue 3, 2010, Pages 252-256

  Kayiran, Sinan Mahir ^a   Paloǧlu, Erhan ^a   Gürakan, Berkan ^a  

^a AMERICAN HOSPITAL   (Turkey)

Author keywords

Children; Lower respiratory tract infection; Respiratory syncytial virus

Indexed keywords

EID: 77956639864     PISSN: 13060015     EISSN: 13086278     Source Type: Journal    
DOI: 10.4274/tpa.45.252     Document Type: Article

References (28)

1. Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003; 48: 209-31. (Abstract) / (PDF)
2. Mcintosh K. Respiratory syncytial virus. In: Behrman RE, Kliegman RM (eds). Nelson Textbook of Pediatrics. 18. edition. Philadelphia: WB Saunders, 2007: 1388-90.
3. Yilmaz G, Uzel N, Isik N, Baysal SU, Aslan S, Badur S. Viral lower respiratory tract infections in children in Istanbul, Turkey. Pediatr Infect Dis J 1999; 18: 173. (Abstract)
4. Kanra G, Tezcan S, Yilmaz G. Turkish National Respiratory Syncytial Virus (RSV) Team. Respiratory syncytial virus epidemiology in Turkey. Turk J Pediatr 2005; 47: 303-8. (Abstract) / (Full Text) / (PDF)
5. Hatipoǧlu S, Arica S, Çelik Y, Öztora S, ŞevketoǧluE, Erkum T. Alt solunum yolu enfeksiyonu tanisiyla hastanemize yatirilan olgularda RSV enfeksiyonu sikliǧi ve klinik özellikleri. Düzce Tip Dergisi 2009; 11: 38-44. (PDF)
6. Hacimustafaoǧlu M, Çelebi S, Aynaci E, Köksal N, Sinirtaş M, Göral G. Evaluation of RSV frequency in acute bronchiolitis by different methods. Çocuk Enf Derg 2008; 4: 156-61. (Abstract) / (Full Text) / (PDF)
7. American Academy of Pediatrics Committee on Infectious Diseases. In: Peter G (ed). 1997 Red Book: Report of the Committee on Infectious Diseases. 24th edition. Elk Grove Village, Illinois: American Academy of Pediatrics, 1976; 89: 11-15.
8. Hacimustafaoǧlu M. RSV İnfeksiyonlari. ANKEM Derg 2006; 20: 240-7. (PDF)
9. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002; 96 Suppl B: S1-7. (Abstract) / (PDF)
10. Figueras-Aloy J, Carbonell-Estrany X, Quero J; IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 2004; 23: 815-20. (Abstract) (Pubitemid 40221022)
11. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774-93. (Abstract) / (Full Text) / (PDF)
12. Comittee on infectious diseases. Policy statement-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009; 124; 2345-55.
13. Morris SK, Dzolganovski B, Beyene J, Sung L. A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection. BMC Infect Dis 2009; 9:106-25. (Abstract) / (Full Text) / (PDF)
14. Jonathan N. Diagnostic utility of BINAX NOW RSV-an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence. Ann Clin Microbiol Antimicrob 2006; 5:13-8. (Abstract) / (Full Text) / (PDF)
15. Selvarangan R, Abel D, Hamilton M. Comparison of BD Directigen EZ RSV and Binax NOW RSV tests for rapid detection of respiratory syncytial virus from nasopharyngeal aspirates in a pediatric population. Diagn Microbiol Infect Dis 2008; 62: 157-61. (Abstract) / (Full Text) / (PDF)
16. Simoes EA. RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes. Manag Care 2008; 17: 3-6. (Abstract)
17. Doering G, Gusenleitner W, Belohradsky BH, Burdach S, Resch B, Liese JG. The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age. Pediatr Infect Dis J 2006; 25: 1188-90. (Abstract) (Pubitemid 44900688)
18. Damore D, Mansbach JM, Clark S, Ramundo M, Camargo CA Jr. Prospective multicenter bronchiolitis study: predicting intensive care unit admissions. Acad Emerg Med 2008; 15: 887-94. (Abstract) / (Full Text) / (PDF)
19. Oddy WH, Sly PD, de Klerk NH, et al. Breast feeding and respiratory morbidity in infancy: a birth cohort study. Arch Dis Child 2003; 88: 224-8. (Abstract) / (PDF)
20. Simões EA, Carbonell-Estrany X, Fullarton JR, et al. A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res 2008; 9: 78-88. (Abstract) / (Full Text) / (PDF)
21. Paes B, Steele S, Janes M, Pinelli J. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada. Curr Med Res Opin 2009; 25: 1585-91. (Abstract) / (Full Text) / (PDF)
22. Erten M, Karayaǧar N, Ergüven M, ve ark. Bronşiyolitli olgularimizda respiratuvar sinsisyal virüs (RSV) infeksiyonu sikliǧinin deǧerlendirilmesi. Göztepe Tip Dergisi 2006; 21:113-5. (Abstract)
23. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171: 137-41. (Abstract) / (Full Text) / (PDF) (Pubitemid 40105412)
24. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005; 16: 386-92. (Abstract) / (Full Text) / (PDF) (Pubitemid 41207478)
25. Kneyber MCJ, Steyerberg EW, de Groot R, Moll HA. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr 2000; 89: 654-60. (Abstract) / (PDF)
26. Valkonen H, Waris M, Ruohola A, Ruuskanen O, Heikkinen T. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up. Allergy 2009; 64: 1359-65. (Abstract) / (Full Text) / (PDF)
27. Simoes EA, Groothuis JR, Tristram DA, et al. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr 1996; 129: 214-9. (Abstract) / (Full Text) / (PDF)
28. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009; 94: 99-103. (Abstract) / (Full Text) / (PDF)